Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00157755 · ClinicalTrials.gov registry record · NA
Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT00157755 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 87 participants.
The verdict
NCT00157755, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study is to evaluate the safety and effectiveness of gastric stimulation in the reduction of nausea and vomiting in patients with gastroparesis using an approved Humanitarian device. There are two cohorts in this study based on etiology, one for diabetic and one for idiopathic. A maximum of 150 patients (75 diabetic and 75 idiopathic) from up to 15 centers in the United States will be followed closely for twelve months and then once a year after that until the study closes. If you are someone suffering with symptoms of gastroparesis despite trying oral medications, you may be eligible to participate in a clinical study using a surgically implanted gastric stimulator.
Interventions
- DEVICE Enterra Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2002-06 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00157755
The ClinicalTrials.gov registry entry for NCT00157755 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterra Therapy is the first listed.
NCT00157755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00157755 about?
NCT00157755 is a clinical study titled "Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)". This study is to evaluate the safety and effectiveness of gastric stimulation in the reduction of nausea and vomiting in patients with gastroparesis using an approved Humanitarian device. There are two cohorts in this study based on etiology, one for diabetic and one for idiopathic. A maximum of 15...
What is the current status of trial NCT00157755?
This trial is currently terminated. It is a NA study. The enrollment target is 87 participants. The study started on 2002-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00157755?
The interventions under investigation include: Enterra Therapy (DEVICE).
Who is sponsoring clinical trial NCT00157755?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.